Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony V Moorman

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
The Lancet. Haematology|October 29, 2021
Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trialsAmir Enshaei, Ajay Vora, Christine J Harrison, et al.
Haematologica|June 4, 2008
Acute leukemia in children with Down's syndrome: the importance of population based studyRebecca James, Tracy Lightfoot, Jill Simpson, et al.
International Journal of Molecular Sciences|January 11, 2022
Genetic Profiles and Risk Stratification in Adult De Novo Acute Myeloid Leukaemia in Relation to Age, Gender, and Ethnicity: A Study from MalaysiaAngeli Ambayya, Anthony V Moorman, Jameela Sathar, et al.
Genes, Chromosomes & Cancer|January 24, 2007
Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycleHazel M Robinson, Christine J Harrison, Anthony V Moorman, et al.
Cancer Genetics and Cytogenetics|January 22, 2004
Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?Rachel L Harris, Christine J Harrison, Mary Martineau, et al.
Genes, Chromosomes & Cancer|August 31, 2004
MLL translocations with concurrent 3' deletions: interpretation of FISH resultsKerry E Barber, Anthony M Ford, Rachel L Harris, et al.
Blood|November 10, 2009
A population-based cytogenetic study of adults with acute lymphoblastic leukemiaAnthony V Moorman, Lucy Chilton, Jennifer Wilkinson, et al.
Pathology|September 11, 2013
Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemiaJohn O'Reilly, Lisa J Russell, Julian Cooney, et al.
The Lancet. Oncology|June 14, 2014
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Chris Mitchell, et al.
British Journal of Haematology|February 19, 2002
Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalitiesPierre Lebailly, Eleanor V Willett, Anthony V Moorman, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
The Lancet. Haematology|October 29, 2021
Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trialsAmir Enshaei, Ajay Vora, Christine J Harrison, et al.
Haematologica|June 4, 2008
Acute leukemia in children with Down's syndrome: the importance of population based studyRebecca James, Tracy Lightfoot, Jill Simpson, et al.
International Journal of Molecular Sciences|January 11, 2022
Genetic Profiles and Risk Stratification in Adult De Novo Acute Myeloid Leukaemia in Relation to Age, Gender, and Ethnicity: A Study from MalaysiaAngeli Ambayya, Anthony V Moorman, Jameela Sathar, et al.
Genes, Chromosomes & Cancer|January 24, 2007
Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycleHazel M Robinson, Christine J Harrison, Anthony V Moorman, et al.
Cancer Genetics and Cytogenetics|January 22, 2004
Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?Rachel L Harris, Christine J Harrison, Mary Martineau, et al.
Genes, Chromosomes & Cancer|August 31, 2004
MLL translocations with concurrent 3' deletions: interpretation of FISH resultsKerry E Barber, Anthony M Ford, Rachel L Harris, et al.
Blood|November 10, 2009
A population-based cytogenetic study of adults with acute lymphoblastic leukemiaAnthony V Moorman, Lucy Chilton, Jennifer Wilkinson, et al.
Pathology|September 11, 2013
Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemiaJohn O'Reilly, Lisa J Russell, Julian Cooney, et al.
The Lancet. Oncology|June 14, 2014
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Chris Mitchell, et al.
British Journal of Haematology|February 19, 2002
Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalitiesPierre Lebailly, Eleanor V Willett, Anthony V Moorman, et al.
Pageof 16